The landscape of metastatic progression patterns across major human cancers

Oncotarget

Volumn 6, Issue 1, 2015, Pages 570-583

  Budczies, Jan ^a,b,f   von Winterfeld, Moritz ^a   Klauschen, Frederick ^a   Bockmayr, Michael ^a   Lennerz, Jochen K ^c   Denkert, Carsten ^a,f   Wolf, Thomas ^d,f   Warth, Arne ^d   Dietel, Manfred ^a   Anagnostopoulos, Ioannis ^a   Weichert, Wilko ^b,d,f   Wittschieber, Daniel ^e   Stenzinger, Albrecht ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f German Consortium for Translational Cancer Research (DKTK)   (Germany)

Author keywords

Autopsy; Cancer; Carcinoma; Metastasis; Solid Tumor; Survival; Systemic Disease

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER GROWTH; CANCER OF UNKNOWN PRIMARY SITE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MIDDLE AGED; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; ADVERSE EFFECTS; CLUSTER ANALYSIS; DISEASE COURSE; NEOPLASM; PATHOLOGY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84921419240     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2677     Document Type: Article

References (50)

1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331:1559-64.
2. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17:1471-4.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-74.
4. Brabletz T, Lyden D, Steeg PS, Werb Z. Roadblocks to translational advances on metastasis research. Nat Med. 2013; 19:1104-9.
5. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002; 2: 563-72.
6. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006; 127: 679-95.
7. Fidler IJ, Poste G. The "seed and soil" hypothesis revisited. Lancet Oncol. 2008; 9:808.
8. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283: 139-46.
9. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009; 9:302-12.
10. Klein CA. Selection and adaptation during metastatic cancer progression. Nature. 2013; 501:365-72.
11. Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013; 19: 1450-64.
12. Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013; 501:338-45.
13. Polzer B, Klein CA. Metastasis awakening: the challenges of targeting minimal residual cancer. Nat Med. 2013; 19: 274-5.
14. Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31: 539-44.
15. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578-83.
16. Elliott JA, Osterlind K, Hirsch FR, Hansen HH. Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients. J Clin Oncol. 1987; 5:246-54.
17. Hugen N, van de Velde CJ, de Wilt JH, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014; 25: 651-7.
18. Klevesath MB, Pantel K, Agbaje O, et al. Patterns of metastatic spread in early breast cancer. Breast. 2013; 22: 449-54.
19. Lee YT. Patterns of metastasis and natural courses of breast carcinoma. Cancer Metastasis Rev. 1985; 4:153-72.
20. Shinagare AB1, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin ME, Van den Abbeele AD. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol. 2011, 196: 117-22.
21. Stenbygaard LE, Sørensen JB, Olsen JE. Metastatic pattern at autopsy in non-resectable adenocarcinoma of the lung--a study from a cohort of 259 consecutive patients treated with chemotherapy. Acta Oncol. 1997; 36:301-6.
22. Stenbygaard LE, Sørensen JB, Olsen JE. Metastatic pattern in adenocarcinoma of the lung. An autopsy study from a cohort of 137 consecutive patients with complete resection. J Thorac Cardiovasc Surg. 1995; 110:1130-5.
23. Weiss L, Harlos JP, Torhorst J, et al. Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol. 1988;114: 605-12.
24. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg. 1978; 135: 807-10.
25. Schön CA, Görg C, Ramaswamy A, Barth PJ. Splenic metastases in a large unselected autopsy series. Pathol Res Pract. 2006, 202:351-6.
26. Leong SP, Cady B, Jablons DM et al. Clinical patterns of metastasis. Cancer Metastasis Rev. 2006, 25:221-32.
27. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer. 1950; 3:74-85.
28. di Sibio G, French SW. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. 2008; 132:931-9.
29. Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006; 106:1624-33.
30. Chen LL, Blumm N, Christakis NA, Barabási AL, Deisboeck TS. Cancer metastasis networks and the prediction of progression patterns. Br J Cancer. 2009; 101: 749-58.
31. Wittschieber D, Klauschen F, Kimmritz AC, et al. Who is at risk for diagnostic discrepancies? Comparison of pre-and postmortal diagnoses in 1800 patients of 3 medical decades in East and West Berlin. PLoS One. 2012; 7:e37460.
32. Budczies J, von Winterfeld M, Klauschen F, et al. Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer. J Clin Pathol. 2014; 67:482-90.
33. Agudo A, Bonet C, Travier N, et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol 2012; 30:4550-7.
34. R Development Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org
35. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003; 13:2498-504.
36. Shannon PT, Grimes M, Kutlu B, Bot JJ, Galas DJ. RCytoscape: tools for exploratory network analysis. BMC Bioinformatics. 2013; 14:217.
37. Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med. 2014; 371: 757-65.
38. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976; 194: 23-8.
39. Ewing, J. Neoplastic Diseases: A Textbook on Tumors. Philadelphia: W. B. Saunders, 1st edition, 1919.
40. Halsted WS. I. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 46: 1-19.
41. Moehrle M, Schippert W, Rassner G, Garbe C, Breuninger H. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for diseasefree survival, distant-metastasis-free survival, and overall survival. Dermatol Surg. 2004; 30: 1319-28.
42. Leong SP, Zuber M, Ferris RL, et al. Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol. 2011; 103: 518-30.
43. Alitalo A, Detmar M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene. 2012; 31: 4499-508.
44. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 133: 571-73.
45. Sobus SL, Warren GW. The biologic effects of cigarette smoke on cancer cells. Cancer. 2014 Jul 9. doi: 10.1002/ cncr.28904. [Epub ahead of print].
46. Helleday T, Eshtad S, Nik-Zainal S. Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet. 2014 Jul 1. doi: 10.1038/nrg3729.
47. Vanharanta S, Massagué J. Origins of metastatic traits. Cancer Cell. 2013; 24:410-21.
48. Baccelli I, Stenzinger A, Vogel V, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014; 5: 8147-60.
49. Comen E, Norton L, Massagué J. Clinical implications of cancer self-seeding. Nat Rev Clin Oncol. 2011; 8: 369-77.
50. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29.